comparative effectiveness of semaglutide and tirzepatide vs bariatric surgery Tirzepatide- Start your WEIGHT LOSS journey today! Consults are free!! You don't have to know which one you need- WE ARE HERE TO HELP YOU! Teaching obesity/weight management this week

According to the **TRIUMPH-1 Phase 3 trial results published by Eli Lilly in May 2026**, Retatrutide at the 12mg maintenance dose produced an average of 28.3% body weight reduction over 80 weeks

2022 Visa MasterCard -,

Back pain is a common and costly condition that nearly 80 percent of adults can experience with around 8 percent living with chronic back pain

Seeing your weight and symptoms organized by dose helps you and your clinician decide whether your maintenance plan is holding steady or needs adjustment

Phase 3: Continued escalation (weeks 9 through 12) Dose: 1.0 mg once weekly At 1 mg, the appetite effects become pronounced for most people